• Latest Posts
In Depth 19 Jun 2023

Gene therapy: a promising solution for sickle cell disease

Patients with beta-thalassemia able to access first approved gene therapy

In Depth 11 Oct 2021

A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology

Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany

More News! 9 Oct 2019

Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing

ADVERTISEMENT

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

First Gene Therapy for Beta Thalassemia Approved in Europe

Gene Therapy For Beta-Thalassemia Could Eliminate Need for Transfusions

Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

What do the CAR-T Patient Deaths Mean for the Future of the Field?

ADVERTISEMENT